BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15007307)

  • 1. Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
    Okazaki H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Yamamoto K; Okada H; Fujita T; Tsuji T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):169-74. PubMed ID: 15007307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
    Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
    Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor.
    Kawada M; Mizuno M; Nasu J; Uesu T; Okazaki H; Okada H; Shimomura H; Yamamoto K; Tsuji T; Fujita T; Shiratori Y
    J Lab Clin Med; 2003 Nov; 142(5):306-12. PubMed ID: 14647034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-specific Ulex europaeus agglutinin-I binding glycoproteins of human colorectal carcinoma and its relation to carcinoembryonic antigen.
    Matsushita Y; Yonezawa S; Nakamura T; Shimizu S; Ozawa M; Muramatsu T; Sato E
    J Natl Cancer Inst; 1985 Aug; 75(2):219-26. PubMed ID: 3894751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.
    Makidono C; Mizuno M; Nasu J; Hiraoka S; Okada H; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):152-8. PubMed ID: 15007304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis.
    Kohno H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Inaba T; Yamamoto K; Okada H; Fujita T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jan; 20(1):73-8. PubMed ID: 15610450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulex europeus type I agglutinin detects carcinoembryonic antigen in extracts of human colorectal carcinoma.
    Jessup JM; Qi KF; Kanellopoulos K; Cleary K; Hickey C; Reading CL
    J Cell Biochem; 1988 Jun; 37(2):193-202. PubMed ID: 2456296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential.
    Irimura T; Ota DM; Cleary KR
    Cancer Res; 1987 Feb; 47(3):881-9. PubMed ID: 3802084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin histochemistry in ulcerative colitis and Crohn's disease.
    Yoshioka H; Inada M; Ogawa K; Ohshio G; Yamabe H; Hamashima Y; Miyake T
    J Exp Pathol; 1989; 4(2):69-78. PubMed ID: 2769448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wheat germ agglutinin and other selected lectins increase synthesis of decay-accelerating factor in human endothelial cells.
    Bryant RW; Granzow CA; Siegel MI; Egan RW; Billah MM
    J Immunol; 1991 Sep; 147(6):1856-62. PubMed ID: 1716283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel.
    Yonezawa S; Nakamura T; Tanaka S; Sato E
    J Natl Cancer Inst; 1982 Oct; 69(4):777-85. PubMed ID: 6181281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
    Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of Ulex europaeus agglutinin-I in polyposis coli: comparative study with solitary adenoma in the sigmoid colon and rectum.
    Yonezawa S; Nakamura T; Tanaka S; Maruta K; Nishi M; Sato E
    J Natl Cancer Inst; 1983 Jul; 71(1):19-24. PubMed ID: 6345880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin UEA-I-binding proteins are specifically increased in the squamous epithelium of patients with Barrett's esophagus.
    Neumann H; Wex T; Mönkemüller K; Vieth M; Fry LC; Malfertheiner P
    Digestion; 2008; 78(4):201-7. PubMed ID: 19129702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peanut lectin binding sites in colons of patients with ulcerative colitis.
    Cooper HS; Farano P; Coapman RA
    Arch Pathol Lab Med; 1987 Mar; 111(3):270-5. PubMed ID: 3827531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the decay-accelerating factor CD55 as a peanut agglutinin-binding protein and its alteration in non-small cell lung cancers.
    Higuchi M; Endo Y; Suzuki H; Osuka F; Shio Y; Fujiu K; Kanno R; Oishi A; Fujita T; Gotoh M
    Clin Cancer Res; 2006 Nov; 12(21):6367-72. PubMed ID: 17085647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis.
    Tahara T; Inoue N; Hisamatsu T; Kashiwagi K; Takaishi H; Kanai T; Watanabe M; Ishii H; Hibi T
    J Gastroenterol Hepatol; 2005 May; 20(5):710-5. PubMed ID: 15853983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histochemical study of colorectal adenocarcinoma by fluorescein isothiocyanate (FITC) conjugated lectins].
    Shi ZR; Yin DY
    Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):196-9. PubMed ID: 3447860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.